(Q47739130)

English

Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications.

scientific article published on 10 January 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

2 references

14 March 2019

24 March 2019

Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications. (English)

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

type-1 diabetes

2 references

14 March 2019

24 March 2019

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/29322308

author name string

Paulo H R F Almeida

1

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

Thales B C Silva

2

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

Francisco de Assis Acurcio

3

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

Augusto A Guerra Júnior

4

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

Vania E Araújo

5

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

Leonardo M Diniz

6

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

Alessandra M Almeida

8

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

Juliana Alvares

9

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2018

3 references

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

14 March 2019

24 March 2019

The Patient: Patient-Centered Outcomes Research

3 references

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

14 March 2019

24 March 2019

11

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

377-389

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

4

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

copyright license

Creative Commons Attribution-NonCommercial

2 references

14 March 2019

24 March 2019

on focus list of Wikimedia project

0 references

https://scigraph.springernature.com/pub.10.1007/s40271-017-0291-3

0 references

Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

27 July 2018

Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

27 July 2018

Quality of life of patients with Diabetes Mellitus Types 1 and 2 from a referal health centre in Minas Gerais, Brazil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

27 July 2018

Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

27 July 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

27 July 2018

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

27 July 2018

Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

27 July 2018

Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

27 July 2018

Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

27 July 2018

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

27 July 2018

The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

27 July 2018

Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

27 July 2018

The clinical effectiveness of insulin glargine in patients with Type I diabetes in Brazil: findings and implications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

14 August 2018

Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

14 August 2018

Evaluation of the quality of life of patients with diabetes mellitus treated with conventional or analogue insulins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

14 August 2018

Insulin glargine in a Brazilian state: should the government disinvest? An assessment based on a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

14 August 2018

Lower HbA1c after 1 year, in children with type 1 diabetes treated with insulin glargine vs. NPH insulin from diagnosis: a retrospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

14 August 2018

Intermediate acting versus long acting insulin for type 1 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

14 August 2018

Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

14 August 2018

Long-term efficacy of insulin glargine therapy with an educational programme in type 1 diabetes patients in clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

14 August 2018

Glycaemic control and hypoglycaemia in children, adolescents and young adults with unstable type 1 diabetes mellitus treated with insulin glargine or intermediate-acting insulin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

14 August 2018

Use of insulin glargine in children under age 6 with type 1 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

14 August 2018

Prospective audit of the introduction of insulin glargine (lantus) into clinical practice in type 1 diabetic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

14 August 2018

Scope and impact of financial conflicts of interest in biomedical research: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

14 August 2018

Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

14 August 2018

A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

14 August 2018

Understanding Financial Conflicts of Interest

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

14 August 2018

Reliability and Validity of a Diabetes Quality-of-Life Measure for the Diabetes Control and Complications Trial (DCCT)

1 reference

https://api.crossref.org/works/10.1007%2FS40271-017-0291-3

21 January 2018

Industry sponsorship and research outcome.

1 reference

https://api.crossref.org/works/10.1007%2FS40271-017-0291-3

21 January 2018

Insulin glargine improves glycemic control and health-related quality of life in type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6019415

2 November 2018

The World Health Organization quality of life assessment (WHOQOL): Development and general psychometric properties

1 reference

https://api.crossref.org/works/10.1007%2FS40271-017-0291-3

21 January 2018

Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/29322308

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Quality of life and health: conceptual and methodological issues]

1 reference

https://pubmed.ncbi.nlm.nih.gov/29322308

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/29322308

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Assessment instruments for a Health-Related Quality of Life in diabetes mellitus]

1 reference

https://pubmed.ncbi.nlm.nih.gov/29322308

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40271-017-0291-3

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

1 reference

Europe PubMed Central

15 July 2018

http://europepmc.org/abstract/PMC/6019415

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47739130&oldid=1616626952"